Zotiraciclib API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Zotiraciclib is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Zotiraciclib or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Zotiraciclib API 1204918-72-8?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Zotiraciclib. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Zotiraciclib
- Synonyms:
- Cas Number:
- 1204918-72-8
- DrugBank number:
- DB16656
- Unique Ingredient Identifier:
- 40D08182TT
General Description:
Zotiraciclib, identified by CAS number 1204918-72-8, is a notable compound with significant therapeutic applications. Zotiraciclib is under investigation in clinical trial NCT02942264 (Zotiraciclib (TG02) Plus Dose-dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma).
Categories:
Zotiraciclib is categorized under the following therapeutic classes: Cyclin-Dependent Kinases, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.